Vertex

Key TakeawaysInspiroGene's partnership with Vertex expands CASGEVY availability, potentially improving patient outcomes. Utilizing McKesson's robust distribution networks ensures efficient delivery of CASGEVY to...

Key TakeawaysVertex's new Vanza Triple combination shows non-inferiority to TRIKAFTA® and demonstrates further improvements in CFTR function in Phase 3 trials. Long-term data...

The Institute for Clinical and Economic Review (ICER) has announced its plan to evaluate the comparative clinical effectiveness and value of suzetrigine (Vertex Pharmaceuticals)...

Vertex Pharmaceuticals Incorporated has reached a significant achievement in the realm of severe sickle cell disease and beta thalassemia treatment with the European Commission...

Vertex Pharmaceuticals achieved a significant milestone in July 2023 when the European Commission granted an expanded label for KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) with ivacaftor, specifically for...